Physician profile
Tiffany Chen
NPI 1306299078
$2,773.16
in general payments reported to CMS, 2019-2025
12 companies · $488 in 2025
The $488 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $150 · 2021: $65.99 · 2022: $384 · 2023: $570 · 2024: $807 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Consulting Fee: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.10 |
| Consulting Fee | $390.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $922.66 | 2019-2025 | Acuvue, Axert |
| Coopervision INC. | $476.95 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Biotissue Holdings INC. | $341.51 | 2024-2025 | |
| Alcon Vision LLC | $273.49 | 2019-2025 | Precision 1, Precision7, Dailies Total1 |
| Bausch & Lomb Americas INC. | $220.91 | 2024 | Zenlens, Infuse |
| Glaukos Corporation | $143.73 | 2022 | |
| Novartis Pharmaceuticals Corporation | $118.77 | 2019 | |
| Sun Pharmaceutical Industries INC. | $108.78 | 2020-2021 | |
| Dompe US, INC. | $70.38 | 2024 | Oxervate |
| Synergeyes, INC. | $39.94 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.